ELIQUIS
BRISTOL MYERS SQUIBB · APIXABAN
Open FDA's page for this record- Application number
- NDA202155
- Sponsor name
- BRISTOL MYERS SQUIBB
- Submissions
- Submission type
- SUPPL
- Submission number
- 20
- Submission status
- AP
- Submission status date
- 20180628
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 54762
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202155s020lbl.pdf
- Date
- 20180705
- Type
- Label
- ID
- 54836
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/202155Orig1s020ltr.pdf
- Date
- 20180706
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 12
- Submission status
- AP
- Submission status date
- 20160720
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 40134
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202155s012lbl.pdf
- Date
- 20160721
- Type
- Label
- ID
- 9979
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/202155Orig1s012ltr.pdf
- Date
- 20160722
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 10
- Submission status
- AP
- Submission status date
- 20150616
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 19076
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202155s010lbl.pdf
- Date
- 20150619
- Type
- Label
- ID
- 32197
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202155Orig1s010ltr.pdf
- Date
- 20150618
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 39
- Submission status
- AP
- Submission status date
- 20250417
- Review priority
- PRIORITY
- Submission class code
- EFFICACY
- Submission class code description
- Efficacy
- Application docs
- ID
- 82023
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/202155Orig1s039, s040ltr.pdf
- Date
- 20250428
- Type
- Letter
- ID
- 84394
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/202155Orig1s039,s040lbl.pdf
- Date
- 20251212
- Type
- Label
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20121228
- Review priority
- PRIORITY
- Submission class code
- TYPE 1
- Submission class code description
- Type 1 - New Molecular Entity
- Application docs
- ID
- 9975
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202155Orig1s000ltr.pdf
- Date
- 20130102
- Type
- Letter
- ID
- 19071
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202155s000lbl.pdf
- Date
- 20121231
- Type
- Label
- ID
- 22875
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202155Orig1s000TOC.html
- Date
- 20130213
- Type
- Review
- Submission type
- SUPPL
- Submission number
- 8
- Submission status
- AP
- Submission status date
- 20150501
- Review priority
- PRIORITY
- Submission class code
- MANUF (CMC)
- Submission class code description
- Manufacturing (CMC)
- Submission type
- SUPPL
- Submission number
- 6
- Submission status
- AP
- Submission status date
- 20140821
- Review priority
- STANDARD
- Submission class code
- EFFICACY
- Submission class code description
- Efficacy
- Application docs
- ID
- 9976
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/202155Orig1s006ltr.pdf
- Date
- 20140910
- Type
- Letter
- ID
- 19075
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202155s006lbl.pdf
- Date
- 20140909
- Type
- Label
- Submission type
- SUPPL
- Submission number
- 17
- Submission status
- AP
- Submission status date
- 20171129
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 50532
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202155s017lbl.pdf
- Date
- 20171130
- Type
- Label
- ID
- 50563
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/202155Orig1s017ltr.pdf
- Date
- 20171201
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 4
- Submission status
- AP
- Submission status date
- 20131031
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 19074
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202155Orig1s004lbl.pdf
- Date
- 20131119
- Type
- Label
- ID
- 32196
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/202155Orig1s004ltr.pdf
- Date
- 20131106
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 2
- Submission status
- AP
- Submission status date
- 20140130
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 19072
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202155s002lbl.pdf
- Date
- 20140131
- Type
- Label
- ID
- 22876
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/202155Orig1s002TOC.html
- Date
- 20140321
- Type
- Review
- ID
- 32194
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/202155Orig1s002ltr.pdf
- Date
- 20140204
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 21
- Submission status
- AP
- Submission status date
- 20190603
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 58969
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202155s021lbl.pdf
- Date
- 20190604
- Type
- Label
- ID
- 58977
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/202155Orig1s021ltr.pdf
- Date
- 20190605
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 13
- Submission status
- AP
- Submission status date
- 20160503
- Review priority
- PRIORITY
- Submission class code
- MANUF (CMC)
- Submission class code description
- Manufacturing (CMC)
- Application docs
- ID
- 44989
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/202155Orig1s013.pdf
- Date
- 20160503
- Type
- Review
- +13 more not shown
- Products
- Product number
- 003
- Reference drug
- Yes
- Brand name
- ELIQUIS
- Reference standard
- Yes
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Active ingredients
- Name
- APIXABAN
- Strength
- 0.5MG
- Product number
- 001
- Reference drug
- Yes
- Brand name
- ELIQUIS
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- APIXABAN
- Strength
- 2.5MG
- Product number
- 002
- Reference drug
- Yes
- Brand name
- ELIQUIS
- Reference standard
- Yes
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- APIXABAN
- Strength
- 5MG
- Harmonized identifiers (openFDA)
- Application number
- NDA202155
- Brand name
- ELIQUIS, ELIQUIS 30-DAY STARTER PACK
- Generic name
- APIXABAN
- Manufacturer name
- E.R. Squibb & Sons, L.L.C.
- Product NDC
- 0003-0893, 0003-0894, 0003-3764, 0003-1028, 0003-0898
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- APIXABAN
- RxCUI
- 1364435, 1364441, 1364445, 1364447, 1992427, 1992428, 2749579, 2749583, 2749685, 2749689, 2749694, 2749695, 2749697, 2749698, 2749699, 2749700
- SPL ID
- 188961fc-00f8-4848-a611-c3c85764baf8
- SPL set ID
- e9481622-7cc6-418a-acb6-c5450daae9b0
- Package NDC
- 0003-0893-21, 0003-0893-31, 0003-0893-91, 0003-0894-21, 0003-0894-70, 0003-0894-31, 0003-0894-91, 0003-3764-74, 0003-1028-28, 0003-1028-84, 0003-1028-12, 0003-0898-28
- Nui
- N0000175637, N0000175635
- Pharm class epc
- Factor Xa Inhibitor [EPC]
- Pharm class moa
- Factor Xa Inhibitors [MoA]
- UNII
- 3Z9Y7UWC1J
